Many of these kinases are involved in the deregulated activation of the MEK/ERK and PI3K/AKT pathway, including PDK1 and Casein kinase II, CK2, with involvement in chemotherapeutic drug resistance, proliferation of cancer initiating cells and angiogenesis [27]. This evidence concerns the gene MAP2K7 and cancer.